Breaking News Instant updates and real-time market news.

COTY

Coty

$12.15

0.675 (5.88%)

, ABB

ABB

$19.59

-0.0428 (-0.22%)

08:45
05/07/19
05/07
08:45
05/07/19
08:45

Largest borrow rate increases among liquid names

Latest data shows the largest indicative borrow rate increases among liquid option names include: Coty (COTY) 2.74% +2.18, ABB (ABB) 3.23% +0.66, TherapeuticsMD (TXMD) 1.96% +0.25, ETFMG Alternative Harvest ETF (MJ) 24.90% +0.07, Papa John's (PZZA) 8.72% +0.07, KraneShares China Internet (KWEB) 0.48% +0.05, Canadian Pacific (CP) 0.31% +0.04, iShares PHLX SOX Semiconductor Sector Index Fund (SOXX) 1.12% +0.02, YETI Holdings (YETI) 14.86% +0.02, and EWW (EWW) 2.06% +0.01.

COTY

Coty

$12.15

0.675 (5.88%)

ABB

ABB

$19.59

-0.0428 (-0.22%)

TXMD

TherapeuticsMD

$4.54

0.18 (4.13%)

MJ

ETFMG Alternative Harvest ETF

$35.59

0.16 (0.45%)

PZZA

Papa John's

$53.43

0.4 (0.75%)

CP

Canadian Pacific

$222.54

-0.46 (-0.21%)

YETI

Yeti

$30.13

-1.3 (-4.14%)

EWW

iShares MSCI Mexico

$45.69

-0.33 (-0.72%)

  • 07

    May

  • 07

    May

  • 07

    May

  • 08

    May

  • 08

    May

  • 17

    May

  • 23

    May

  • 05

    Jun

  • 13

    Nov

  • 09

    May

COTY Coty
$12.15

0.675 (5.88%)

04/17/19
STFL
04/17/19
DOWNGRADE
STFL
Hold
Coty downgraded to Hold from Buy at Stifel
04/16/19
04/16/19
UPGRADE
Target $15

Buy
e.l.f. Beauty upgraded to Buy at DA Davidson on increased shelf space presence
As previously reported, DA Davidson analyst Linda Bolton Weiser upgraded e.l.f. Beauty to Buy from Hold and raised her price target to $15 from $7. The analyst cites the findings of her proprietary store checks suggesting that the company products have seen a 17% increase in shelf space at Target (TGT), overtaking Coty's (COTY) Covergirl brand, while its Q1 sales "inflected from down high-single digits" in Q4 to low-single digits. Weiser believes that her FY20 sales forecast of a 2% decline may be conservative based on these findings.
04/02/19
SBSH
04/02/19
DOWNGRADE
Target $12
SBSH
Neutral
Coty downgraded to Neutral from Buy at Citi
Citi analyst Wendy Nicholson downgraded Coty to Neutral from Buy and lowered her price target for the shares to $12 from $13. The analyst cites valuation for the downgrade following the stock's year-to-date rally.
04/17/19
04/17/19
DOWNGRADE
Target $12

Hold
Coty downgraded to Hold from Buy at Stifel
As previously reported, Stifel analyst Mark Astrachan downgraded Coty to Hold and kept his price target at $12, saying the stock is faced with an "increased risk of sustaining modest sales growth and weakening investor confidence in the business turnaround." While the analyst anticipates "only minor residual impact" from supply disruptions on Q3 results, he sees the outlook for Consumer Beauty remaining muted and also points to the company's debt levels and free cash flows limiting its strategic optionality.
ABB ABB
$19.59

-0.0428 (-0.22%)

03/04/19
DNBM
03/04/19
DOWNGRADE
DNBM
Hold
ABB downgraded to Hold from Buy at DNB Markets
01/28/19
BREN
01/28/19
DOWNGRADE
BREN
Sell
ABB downgraded to Sell from Hold at Berenberg
Berenberg analyst Simon Toennessen downgraded ABB to Sell saying recent money supply trends suggest the company's order growth could fall by double-digits. The analyst cut his price target for the shares to CHF 17.50 from CHF 21.
01/15/19
RBCM
01/15/19
INITIATION
RBCM
Sector Perform
ABB initiated with a Sector Perform at RBC Capital
01/10/19
VERT
01/10/19
DOWNGRADE
Target $17
VERT
Sell
ABB downgraded to Sell from Hold at Vertical Research
Vertical Research analyst Jeffrey Sprague downgraded ABB to Sell and lowered his price target for the shares to $17 from $25. The analyst says that even before the recent drop in oil prices and mounting trade pressures on China he was concerned the company's backlog was insufficient to support its 2019 outlook.
TXMD TherapeuticsMD
$4.54

0.18 (4.13%)

02/06/19
JEFF
02/06/19
DOWNGRADE
Target $5
JEFF
Hold
TherapeuticsMD assumed with a Hold from Buy at Jefferies
Jefferies analyst Chris Howerton assumed coverage of TherapeuticsMD and downgraded his firm's rating to Hold from Buy. He also dropped the stock's price target to $5 from $15. While recognizing the company's large total addressable market, the analyst is cautious on the commercial success of TherapeuticsMD' assets due to a mature market and their "relatively low innovation." Further, he expects erosion of the hormone replacement therapy market for vasomotor symptoms with "innovative therapies" expected to come to market in the next five years.
04/18/19
CANT
04/18/19
NO CHANGE
Target $27
CANT
Overweight
Cantor reiterates $27 price target on TherapeuticsMD after Bijuva launch
Cantor Fitzgerald analyst Louise Chen reiterates an Overweight rating on TherapeuticsMD with a $27 price target after the company announced yesterday that it has launched Bijuva and signed a binding commitment letter for a $300M term loan. The analyst says both announcements underscore her positive investment thesis and belief that the peak sales potential for Imvexxy, Bijuva and Annovera are all underappreciated.
04/30/19
NBLE
04/30/19
INITIATION
NBLE
Outperform
TherapeuticsMD reinstated with an Outperform at Noble Capital
01/07/19
CANT
01/07/19
NO CHANGE
Target $27
CANT
Overweight
TherapeuticsMD shares underappreciate three launches, says Cantor Fitzgerald
In a research note titled "I'm Vexxyed By TXMD's Stock Price," Cantor Fitzgerald analyst Louise Chen reaffirms an Overweight rating on TherapeuticsMD with a $27 price target. The execution of the Imvexxy, Bijuva and Annovera launches is underappreciated, Chen tells investors. She thinks peak sales could exceed "modest expectations for the three drugs that target large unmet needs." Discussions with two experienced OB-GYNs that have already prescribed Imvexxy and are excited to prescribe Bijuva and Annovera support a positive investment thesis on the stock, adds the analyst.
MJ ETFMG Alternative Harvest ETF
$35.59

0.16 (0.45%)

PZZA Papa John's
$53.43

0.4 (0.75%)

04/01/19
KERI
04/01/19
UPGRADE
KERI
Buy
Papa John's upgraded to Buy from Neutral at Kalinowski
03/27/19
STFL
03/27/19
UPGRADE
Target $45
STFL
Hold
Papa John's upgraded to Hold from Sell at Stifel
Stifel analyst Chris O'Cull upgraded Papa John's International to Hold from Sell and raised his price target for the shares to $45 from $35. The analyst believes the company's turnaround has entered a phase where investors believe the worst is behind it "and are willing to accord the company a hall pass to see whether the sales plan can work." The more optimistic sentiment stems from the view that the new board of directors and new brand spokesperson Shaquille O'Neal can reverse the declining traffic and EBITDA trends, O'Cull tells investors in a research note titled "Sell Thesis Not a Slam Dunk; Investors Optimism Outweighing Fundamentals." The analyst remains concerned that low franchisee profits will require ongoing financial support from Papa John's and declining transactions will pressure commissary profits, but he believes investor optimism will likely outweigh these fundamental issues in the near-term.
02/27/19
SPHN
02/27/19
NO CHANGE
Target $55
SPHN
Overweight
Papa John's guidance better than feared, says Stephens
Stephens analyst Will Slabaugh said Papa John's February update was "somewhat encouraging" and that the company's guidance for FY19 was "better than feared." While he expects sales and margins to remain pressured throughout 2019, Slabaugh thinks market expectations are for a choppy recovery and the quarterly report "helped to keep the hope for $2.00 in EPS power alive," he tells investors. He maintains an Overweight rating and $55 price target on Papa John's shares.
03/27/19
03/27/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Bed Bath & Beyond (BBBY) upgraded to Hold from Sell at Loop Capital with analyst Anthony Chukumba citing the recent proxy contest threat was posed by an activist hedge fund consortium amassing 5% of the company stock. 2. Papa John's (PZZA) upgraded to Hold from Sell at Stifel with analyst Chris O'Cull saying he believes the company's turnaround has entered a phase where investors believe the worst is behind it "and are willing to accord the company a hall pass to see whether the sales plan can work." 3. ON Semiconductor (ON) upgraded to Buy from Neutral at Goldman Sachs with analyst Mark Delaney saying while not immune to cyclical risks, ON has improved its exposure to secular opportunities in advanced driver assistance system image sensors, electric vehicles and the cloud. 4. Ralph Lauren (RL) upgraded to Outperform from Market Perform at Wells Fargo with analyst Ike Boruchow saying he views the company as a "rare standout" in his space, with increased visibility, running ahead of plan and with the potential for accelerating growth in the years ahead. 5. Lumentum (LITE) upgraded to Overweight from Equal Weight at Morgan Stanley. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
CP Canadian Pacific
$222.54

-0.46 (-0.21%)

03/12/19
03/12/19
DOWNGRADE

Market Perform
Canadian Pacific downgraded to Market Perform at Bernstein
As previously reported, Bernstein analyst David Vernon downgraded Canadian Pacific to Market Perform from Outperform as he thinks 2019 will represent a peak rate of near-term earnings growth for the company, making it difficult for the stock to re-rate to a higher multiple. While strong execution can help Canadian Pacific deliver bullish top line expectations, Vernon thinks it will be difficult for the company to sustain elevated rates of top line and EBIT growth given the uncertain macro environment. As such, the analyst believes the company will perform more in line with the market over the next year.
04/12/19
DESJ
04/12/19
DOWNGRADE
DESJ
Hold
Canadian Pacific downgraded to Hold from Buy at Desjardins
03/18/19
DBAB
03/18/19
NO CHANGE
DBAB
Deutsche lowers estimates for Canadian Pacific, Canadian National
Deutsche Bank analyst Seldon Clarke lowered his estimates for both Canadian Pacific (CP) and Canadian National (CNI) to reflect weaker than expected volume trends and higher costs related to weather. The analyst, however, remains positive over the mid/long term for both companies given his expectation for "best-in-class" volume growth and continued improvements in profitability. He reduced his price target for Canadian Pacific to $230 from $248.
03/12/19
BERN
03/12/19
DOWNGRADE
BERN
Market Perform
Canadian Pacific downgraded to Market Perform from Outperform at Bernstein
YETI Yeti
$30.13

-1.3 (-4.14%)

04/11/19
04/11/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Lyft (LYFT) initiated with a Hold at HSBC. 2. Apple (AAPL), Dell Technologies (DELL), and HP Inc. (HPQ) initiated with a Neutral at Credit Suisse. 3. Yeti (YETI) initiated with an Outperform at Cowen. 4. CVS Health (CVS) initiated with a Market Perform at BMO Capital. 5. Canadian Solar (CSIQ) assumed with a Neutral at JPMorgan. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/02/19
BARD
05/02/19
NO CHANGE
Target $38
BARD
Outperform
Yeti earnings selloff a buying opportunity, says Baird
Baird analyst Peter Benedict recommends using the post-earnings selloff today in shares of Yeti as a buying opportunity. The analyst says that while expectations were high heading into the print, he's surprised by today's 10%-plus pullback. The company delivered a "high-quality" beat and increased fiscal 2019 earnings guidance by ~2%, Benedict tells investors in a research note. He remains bullish on Yeti with an Outperform rating and $38 price target.
05/03/19
GSCO
05/03/19
DOWNGRADE
Target $33
GSCO
Neutral
Yeti downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs analyst Alexandra Walvis downgraded Yeti Holdings to Neutral from Buy while raising her price target for the shares to $33 from $31. The company's "strong" sales and brand momentum are now better understood by investors, Walvis tells investors in a research note following its Q1 results. The analyst sees a more balanced risk/return profile at current valuation levels.
05/03/19
05/03/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Yeti (YETI) downgraded to Neutral from Buy at Goldman Sachs with analyst Alexandra Walvis saying the company's "strong" sales and brand momentum are now better understood by investors. 2. Electronic Arts (EA) downgraded to Neutral at MKM Partners on valuation with analyst Eric Handler saying the risk-reward on the stock appears to be "less compelling." 3. Cognizant (CTSH) downgraded to Market Perform from Outperform at William Blair, to Underweight from Neutral at JPMorgan, to Neutral from Buy at Goldman Sachs, to Perform from Outperform at Oppenheimer, to Sector Weight from Overweight at KeyBanc, to Neutral from Outperform at Wedbush and to Hold from Strong Buy at Needham after the company's earnings and guidance missed consensus estimates. 4. Target (TGT) downgraded to Market Perform from Outperform at Bernstein with analyst Brandon Fletcher saying he thinks Target's continued emphasis on growth over cost containment is a "less wise" stance at this point. 5. Achillion (ACHN) downgraded to Underweight from Equal Weight at Barclays with analyst Geoffrey Meacham seeing a lack of near- to mid-term catalysts that are capable of changing the story on the stock. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
EWW iShares MSCI Mexico
$45.69

-0.33 (-0.72%)

TODAY'S FREE FLY STORIES

GOOG

Alphabet

$1,132.99

-7.56 (-0.66%)

, GOOGL

Alphabet Class A

$1,138.90

-5.98 (-0.52%)

07:20
05/25/19
05/25
07:20
05/25/19
07:20
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

GOOG

Alphabet

$1,132.99

-7.56 (-0.66%)

GOOGL

Alphabet Class A

$1,138.90

-5.98 (-0.52%)

MSFT

Microsoft

$126.23

0.04 (0.03%)

AMBA

Ambarella

$38.28

1.07 (2.88%)

ON

ON Semiconductor

$17.68

-0.235 (-1.31%)

NKE

Nike

$82.12

-0.51 (-0.62%)

ADDYY

Adidas

$0.00

(0.00%)

UAA

Under Armour

$23.54

0.075 (0.32%)

UA

Under Armour

$20.91

0.08 (0.38%)

FL

Foot Locker

$44.39

-8.455 (-16.00%)

VMC

Vulcan Materials

$126.28

1.25 (1.00%)

FLR

Fluor

$29.04

0.18 (0.62%)

ACM

Aecom

$31.56

-0.03 (-0.09%)

X

U.S. Steel

$13.63

-0.08 (-0.58%)

AKS

AK Steel

$2.00

-0.155 (-7.21%)

NUE

Nucor

$51.12

-0.27 (-0.53%)

DDAIF

Daimler AG

$0.00

(0.00%)

FCAU

Fiat Chrysler

$12.85

0.11 (0.86%)

F

Ford

$9.83

-0.02 (-0.20%)

GM

General Motors

$35.13

0.01 (0.03%)

HMC

Honda

$25.45

0.175 (0.69%)

NSANY

Nissan

$0.00

(0.00%)

TM

Toyota

$118.54

1.16 (0.99%)

VWAGY

Volkswagen

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 03

    Jun

  • 03

    Jun

  • 04

    Jun

  • 04

    Jun

  • 05

    Jun

  • 06

    Jun

  • 08

    Jun

  • 10

    Jun

  • 10

    Jun

  • 11

    Jun

  • 12

    Jun

  • 13

    Jun

  • 19

    Jun

  • 19

    Jun

  • 23

    Jun

  • 09

    Jul

  • 24

    Jul

  • 31

    Jul

  • 01

    Aug

  • 06

    Aug

  • 23

    Oct

  • 27

    Oct

UBER

Uber

$41.40

0.94 (2.32%)

17:49
05/24/19
05/24
17:49
05/24/19
17:49
Hot Stocks
Uber board director Ryan Graves intends to resign »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

APTO

Aptose Biosciences

$2.01

0.03 (1.52%)

17:46
05/24/19
05/24
17:46
05/24/19
17:46
Syndicate
Aptose Biosciences files for $40M at-the-market common stock offering »

Piper Jaffray and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

TRNX

Taronis Technologies

$0.48

0.004 (0.84%)

17:26
05/24/19
05/24
17:26
05/24/19
17:26
Syndicate
Breaking Syndicate news story on Taronis Technologies »

Taronis Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USEG

U.S. Energy

$0.45

0.0373 (9.10%)

17:25
05/24/19
05/24
17:25
05/24/19
17:25
Hot Stocks
U.S. Energy discloses Nasdaq notice regarding delayed 10-Q filing »

U.S. Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$179.03

-0.64 (-0.36%)

17:22
05/24/19
05/24
17:22
05/24/19
17:22
Periodicals
Apple sued over allegedly selling users' iTunes data, Bloomberg says »

Apple is being sued by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

SPCB

SuperCom

$1.17

-0.005 (-0.43%)

17:21
05/24/19
05/24
17:21
05/24/19
17:21
Hot Stocks
SuperCom discloses Nasdaq notice regarding delayed 20-F filing »

SuperCom received a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USEG

U.S. Energy

$0.45

0.0373 (9.10%)

17:20
05/24/19
05/24
17:20
05/24/19
17:20
Hot Stocks
U.S. Energy receives noncompliance notice from Nasdaq »

U.S. Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYOV

Myovant Sciences

$12.39

-0.465 (-3.62%)

17:18
05/24/19
05/24
17:18
05/24/19
17:18
Syndicate
Breaking Syndicate news story on Myovant Sciences »

Myovant Sciences files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYOV

Myovant Sciences

$12.39

-0.465 (-3.62%)

17:17
05/24/19
05/24
17:17
05/24/19
17:17
Syndicate
Breaking Syndicate news story on Myovant Sciences »

Myovant Sciences files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$87.49

3.03 (3.59%)

, QGEN

Qiagen

$38.22

-0.255 (-0.66%)

16:57
05/24/19
05/24
16:57
05/24/19
16:57
Hot Stocks
Qiagen launches diagnostic for PIK3CA biomarkers in breast cancer »

Qiagen (QGEN) announced…

NVS

Novartis

$87.49

3.03 (3.59%)

QGEN

Qiagen

$38.22

-0.255 (-0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 31

    May

  • 20

    Jun

  • 06

    Aug

AVH

Avianca

$3.96

0.91 (29.84%)

16:56
05/24/19
05/24
16:56
05/24/19
16:56
Periodicals
ANAC suspends flights, operations of Avianca Brasil, Reuters reports »

Brazil's ANAC said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$179.03

-0.64 (-0.36%)

16:53
05/24/19
05/24
16:53
05/24/19
16:53
Periodicals
Apple acquires startup Tueo Health, CNBC reports »

Apple has bought Tueo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

SHSP

SharpSpring

$16.37

-0.24 (-1.44%)

16:52
05/24/19
05/24
16:52
05/24/19
16:52
Syndicate
Breaking Syndicate news story on SharpSpring »

SharpSpring files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

CREG

China Recycling Energy

$0.48

0.005 (1.05%)

16:41
05/24/19
05/24
16:41
05/24/19
16:41
Syndicate
Breaking Syndicate news story on China Recycling Energy »

China Recycling Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FENC

Fennec

$3.88

(0.00%)

16:36
05/24/19
05/24
16:36
05/24/19
16:36
Conference/Events
Fennec management to meet with Wedbush »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 18

    Jun

TD

Toronto-Dominion

$56.66

0.65 (1.16%)

16:35
05/24/19
05/24
16:35
05/24/19
16:35
Syndicate
Breaking Syndicate news story on Toronto-Dominion »

Toronto-Dominion files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
05/24/19
05/24
16:30
05/24/19
16:30
Options
Preliminary option volume of 15.7M today »

Preliminary option volume…

CBUS

Cibus

$0.00

(0.00%)

16:25
05/24/19
05/24
16:25
05/24/19
16:25
Syndicate
Cibus requests withdrawal of registration statement »

The company's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$355.14

4.57 (1.30%)

16:23
05/24/19
05/24
16:23
05/24/19
16:23
Periodicals
Boeing 737 MAX return delayed by FAA expanding review, WSJ reports »

A review of Boeing's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 05

    Jun

FB

Facebook

$181.03

0.14 (0.08%)

, BA

Boeing

$355.14

4.57 (1.30%)

16:20
05/24/19
05/24
16:20
05/24/19
16:20
On The Fly
Fly Intel: Wall Street's top stories for Friday »

U.S. stocks, which had a…

FB

Facebook

$181.03

0.14 (0.08%)

BA

Boeing

$355.14

4.57 (1.30%)

UAL

United Continental

$80.77

-0.14 (-0.17%)

SMI

SMIC

$5.23

-0.26 (-4.74%)

HPQ

HP Inc.

$20.03

0.835 (4.35%)

HPE

HP Enterprise

$14.36

0.03 (0.21%)

NVS

Novartis

$87.49

3.03 (3.59%)

CNC

Centene

$56.84

1.39 (2.51%)

WCG

WellCare

$275.45

0.99 (0.36%)

TSS

TSYS

$113.42

13.81 (13.86%)

GPN

Global Payments

$153.42

5.45 (3.68%)

HIBB

Hibbett Sports

$23.91

4.07 (20.51%)

DVAX

Dynavax

$5.77

-0.59 (-9.28%)

FL

Foot Locker

$44.39

-8.455 (-16.00%)

SPLK

Splunk

$119.13

-9.55 (-7.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 24

    May

  • 29

    May

  • 30

    May

  • 30

    May

  • 30

    May

  • 31

    May

  • 03

    Jun

  • 05

    Jun

  • 05

    Jun

  • 05

    Jun

  • 06

    Jun

  • 07

    Jun

  • 08

    Jun

  • 09

    Jun

  • 10

    Jun

  • 13

    Jun

  • 14

    Jun

  • 24

    Jun

  • 24

    Jun

  • 09

    Jul

  • 09

    Jul

  • 23

    Jul

  • 13

    Nov

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
05/24/19
05/24
16:20
05/24/19
16:20
Options
Closing CBOE SPX and VIX Index summary for May 24th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
05/24/19
05/24
16:17
05/24/19
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
05/24/19
05/24
16:16
05/24/19
16:16
Technical Analysis
NYSE market internals summary »

Volume was below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHE

Regional Health Properties

$2.06

0.09 (4.57%)

16:15
05/24/19
05/24
16:15
05/24/19
16:15
Hot Stocks
Regional Health Properties receives NYSE notice over late Form 10-Q filing »

Regional Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.